A bevy of companies are slated to make their public debuts this week, led by a series of international companies.
Pricing Tuesday night
DouYu International Holdings Ltd (NASDAQ:DOYU), a Chinese video game live-streaming platform, expects to bring in $859 million by offering 67.4 million shares between $11.50 and $14. The company has the biggest user base and the highest level of user engagement among live-stream platforms in China, according to iResearch.
Pricing Wednesday night
Genmab A/S (NASDAQ:GMAB), a biotechnology company based in Copenhagen, plans to offer 27.8 million shares at $18.11 per share to raise $503 million. The company is focused on creating antibody treatments for cancer and other diseases, and it plans to launch a proprietary product by 2025. Its pipeline includes five products in clinical development and about 20 proprietary and partnered pre-clinical programs.
AssetMark Financial Holdings Inc (NYSE:AMK), a wealth-management and technology-solutions company based in Concord, California, expects to offer 12.5 million shares between $19 and $21 per share in a bid to raise $250 million. Its platform provides tools to independent financial advisors and their clients.
Phreesia Inc (NASDAQ:PHR), a patient-intake software provider for healthcare companies, hopes to rake in $125 million by offering 7.8 million shares between $15 and $17 per share. The New York company’s namesake SaaS platform offers a patient-intake management system and an integrated-payments system.
Fulcrum Therapeutics Inc (NASDAQ:FULC), a clinical-stage biopharmaceutical company, is looking to raise $77 million by offering 4.5 million shares between $16 and $18. The Cambridge, Massachusetts company is focused on rare genetically defined diseases. Losmapimod, its product candidate for facioscapulohumeral muscular dystrophy, is expected to be part of a Phase 2b clinical trial in mid 2019.
Mirum Pharmaceuticals Inc (NASDAQ:MIRM), a Foster City, California-based biopharmaceutical company, plans to raise $75 million by offering 5 million shares between $14 and $16. Its treatment pipeline consists of a pair of clinical-stage candidates to treat progressive familial intrahepatic cholestasis and Alagille syndrome, disorders that affect the liver.
Pricing Thursday night
Intercorp Financial Services Inc (NASDAQ:IFS), a Peruvian wealth-management company, hopes to raise $423 million by offering 9 million shares between $44 and $50 per share. The company’s digital platform and distribution network offers its 3 million customers access to its banking, insurance and wealth-management products and services.
Afya Ltd (NASDAQ:AFYA), a Brazilian healthcare education company, hopes to raise $234 million by offering 13.7 million shares between $16 and $18 per share. Its network, the largest in Brazil, is made up of 14 undergraduate and graduate medical school campuses with 9 operating units and 5 approved units.
Medallia Inc (NASDAQ:MDLA), an enterprise software company from San Francisco, expects to offer 14.5 million shares between $16 and $18 per share to raise $247 million. Its signature SaaS platform, the Medallia Experience Cloud, helps businesses gather data from their customers and deliver insight in real time.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel